stimlabs.comCorplex P/ Theracor P/ Allacor P
Stimlabs, LLC
STIMLABS, LLC
FDA Registration(s)
| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|---|---|---|---|---|---|
| 3012823434 | 3012823434 | STIMLABS, LLC | 1 | Y | 2026-01-01 | 1225 Northmeadow Parkway Suite 104 Roswell GA US 30076 |
GUDID Contact Samples
| Source GUDID | Product | Phone | |
|---|---|---|---|
| 00850039927348 | Allacor P - Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound. | 1-(888) 346-9802 | customerservice@stimlabs.com |
| 00850039927355 | Allacor P - Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound. | 1-(888) 346-9802 | customerservice@stimlabs.com |
Registered Device Listings
| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|---|---|---|---|---|
| 329764 | 1987696403 | K231325 | Corplex P / Theracor P / Allacor P | KGN | 2024-02-02 |
| 329764 | 1523463929 | K182838 | Geistlich Derma-Gide | KGN | 2018-11-08 |
| 329764 | 1603364262 | K122502 | BRIDGE EXTRACELLULAR COLLEGEN MATRIX | KGN | 2013-02-26 |
Product Codes Associated With Registrations
| Product code | Registration listing records | Latest decision |
|---|---|---|
| KGN | 3 | 2024-02-02 |
PMN
Corplex P / Theracor P / Allacor P
Stimlabs, LLC
GUDID
Allacor P - Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2025-03-05
Allacor P - Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2025-03-05
Allacor P - Allacor P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2025-03-05
Corplex P - Corplex P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Corplex P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2024-07-29
Corplex P - Corplex P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Corplex P/Theracor P/Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2024-07-29
Corplex P - Corplex P is derived from human umbilical cord extracellular matrix (ECM) and is indicated for the management of a range of acute and chronic wounds. As a resorbable particulate device, Corplex P/Theracor P/Allacor P is lyophilized and packaged in a sterile vial, allowing the device to be rehydrated and applied directly to the wound.
2024-07-29